At present, α-fetoprotein (AFP) measurement is the conventional estimated standard for the diagnosis and prognosis of HCC patients; however, the testing effect is not sensitive and specific enough due to the interference of HCC-unrelated factors and tumor heterogeneity (31). This evidence concerns the gene AFP and hepatocellular carcinoma.